Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

125.67 +8.36 (+7.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,095,251
Open 119.47
Bid (Size) 125.54 (1)
Ask (Size) 125.57 (1)
Prev. Close 117.31
Today's Range 119.03 - 126.88
52wk Range 62.55 - 133.16
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
As 'Roaring Kitty' Returns, Here Are 3 ETFs To Leverage The 2024 Meme Stock Wave
Meme stocks, led by Keith Gill, have resurfaced on social media, causing GameStop's stock to surge by 74% and AMC's by 80%. ETFs like ARCA:STCE can capitalize on this trend. 
Via Benzinga
Topics ETFs
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Via Benzinga

Performance

YTD
+11.71%
+11.71%
1 Month
+21.00%
+21.00%
3 Month
+41.20%
+41.20%
6 Month
+78.99%
+78.99%
1 Year
-3.32%
-3.32%

More News

Read More
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Via The Motley Fool
Moderna to Present at Upcoming Conferences in May/June 2024
Via ACCESSWIRE
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Via The Motley Fool
Moderna Announces Update on Investigational RSV Vaccine
Via ACCESSWIRE
Check Out What Whales Are Doing With MRNA
Via Benzinga
Moderna's Options Frenzy: What You Need to Know
Via Benzinga
The 10 Worst Performing S&P 500 Stocks in 2023 - Are They Good Investments Now?
Via Talk Markets
Topics Stocks
Exposures US Equities
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
Via Benzinga
Exposures Product Safety
Navigating 6 Analyst Ratings For Moderna
Via Benzinga
Moderna Dives Back Into Buy Zone After FDA Delays Its RSV Vaccine
Via Investor's Business Daily
Exposures Product Safety
Will the Biotech Sector Shift From Lagger to Leader?
Via MarketBeat
Topics ETFs
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Exposures COVID-19
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Via InvestorPlace
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Via FinancialNewsMedia
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
From FN Media Group LLC
Via GlobeNewswire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Via MarketBeat
Exposures COVID-19
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
Via Benzinga
MSFT Analysis: Why Microsoft Stock Is a Must-Own for Investors in 2024
Via InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.